These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2501400)

  • 1. Detection of five circulating antigens in patients with head and neck squamous cell carcinoma.
    Screm MC; Grandis S; Cartei G; Cattaruzzi E
    Int J Biol Markers; 1989; 4(1):35-9. PubMed ID: 2501400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of tumor markers in the management of head and neck cancer.
    Rosati G; Riccardi F; Tucci A
    Int J Biol Markers; 2000; 15(2):179-83. PubMed ID: 10883893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum SCC-Ag in head and neck squamous cell carcinoma.
    Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C
    Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
    Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E
    Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck.
    Ogawa T; Tsurusako Y; Kimura N; Nishioka S; Akagi H; Nishizaki K; Nishioka K; Rutka J
    Acta Otolaryngol Suppl; 1999; 540():72-6. PubMed ID: 10445084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of intercellular adhesion molecule-1 in squamous cell carcinoma of the head and neck.
    Wollenberg B; Jan N; Sautier W; Hofmann K; Schmitt UM; Stieber P
    Tumour Biol; 1997; 18(2):88-94. PubMed ID: 9222306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
    Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
    Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
    Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
    Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma antigen (SCC), carcinoembryonic antigen (CEA), and tumour-associated trypsin inhibitor (TATI) for monitoring head and neck cancer.
    Pectasides D; Bourazanis J; Economides N; Pozadzidou P; Gogou L; Koutsiouba P; Athanassiou A
    Int J Biol Markers; 1993; 8(2):81-7. PubMed ID: 8366300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125.
    Straka MB; Wagner RL; Johnson JT; Kachman KK; Eibling DE
    Arch Otolaryngol Head Neck Surg; 1992 Aug; 118(8):802-5. PubMed ID: 1642830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor markers in patients with head-neck carcinomas].
    Walther EK; Dahlmann N; Gorgulla HT
    Laryngorhinootologie; 1990 May; 69(5):271-4. PubMed ID: 2354022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity.
    Kurokawa H; Tsuru S; Okada M; Nakamura T; Kajiyama M
    Int J Oral Maxillofac Surg; 1993 Feb; 22(1):35-8. PubMed ID: 7681461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differences in assay sensitivity of selected tumor markers in head and neck neoplasms].
    Adamiak G; Jurkiewicz D; Polberg K; Konieczna M
    Otolaryngol Pol; 1995; 49 Suppl 20():99-101. PubMed ID: 9454232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of tumor markers in the follow up of malignant neoplasms of the head and neck].
    Grandis S; Screm MC; Cartei G
    Acta Otorhinolaryngol Ital; 1989; 9(6):599-604. PubMed ID: 2699147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
    Dreyfuss AI; Clark JR; Andersen JW
    Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
    Zöller J; Fiehn W; Mende U; Hotz G
    Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(4):254-9. PubMed ID: 2134649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinomas after radiotherapy.
    Shirato H; Ichimura W; Wakushima H; Nishioka T; Suzuki K
    Acta Oncol; 1993; 32(6):663-6. PubMed ID: 8260185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.